Vascular Outcome in Patients With Homocystinuria due to Cystathionine β-Synthase Deficiency Treated Chronically: A Multicenter Observational Study
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
An inborn error of metabolism, homocystinuria due to cystathionine β-synthase deficiency, results in markedly elevated levels of circulating homocysteine. Premature vascular events are the main life-threatening complication. Half of all untreated patients have a vascular event by 30 years of age. We performed a multicenter observational study to assess the effectiveness of long-term homocysteine-lowering treatment in reducing vascular risk in 158 patients. Vascular outcomes were analyzed and effectiveness of treatment in reducing vascular risk was evaluated by comparison of actual to predicted number of vascular events, with the use of historical controls from a landmark study of 629 untreated patients with cystathionine β-synthase deficiency. The 158 patients had a mean (range) age of 29.4 (4.5 to 70) years; 57 (36%) were more than 30 years old, and 10 (6%) were older than 50 years. There were 2822 patient-years of treatment, with an average of 17.9 years per patient. Plasma homocysteine levels were markedly reduced from pretreatment levels but usually remained moderately elevated. There were 17 vascular events in 12 patients at a mean (range) age of 42.5 (18 to 67) years: pulmonary embolism (n=3), myocardial infarction (n=2), deep venous thrombosis (n=5), cerebrovascular accident (n=3), transient ischemic attack (n=1), sagittal sinus thrombosis (n=1), and abdominal aortic aneurysm (n=2). Without treatment, 112 vascular events would have been expected, for a relative risk of 0.09 (95% CI 0.036 to 0.228; P <0.0001). Treatment regimens designed to lower plasma homocysteine significantly reduce cardiovascular risk in cystathionine β-synthase deficiency despite imperfect biochemical control. These findings may be relevant to the significance of mild hyperhomocysteinemia that is commonly found in patients with vascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
The natural history of homocystinuria due to cystathionine beta-synthase deficiency.
Mudd, S. H., Skovby, F., Levy, H. L., Pettigrew, K. D., Wilcken, B. M., Pyeritz, R. E., Andria, G., Boers, G. H. J., Bromberg, I. L., & Cerone, R. (1985) · PubMed · Cited by 1,256
Self-citationHomocysteine and vascular disease
Hankey, G. J., & Eikelboom, J. W. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11058-9 · Cited by 1,052
Mudd, S. H. (1989) · Medical Entomology and Zoology · Cited by 1,019
Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease
Boers, G. H. J., Smals, A. G. H., Trijbels, F. J. M., Fowler, B., Bakkeren, J. A. J. M., Schoonderwaldt, H. C., Kleijer, W. J., & Kloppenborg, P. W. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509193131201 · Cited by 732
Self-citationThe pathogenesis of coronary artery disease. A possible role for methionine metabolism.
Wilcken, D. E., & Wilcken, B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108350 · Cited by 529
Self-citationThe controversy over homocysteine and cardiovascular risk
Ueland, P. M., Refsum, H., Beresford, S. A., & Vollset, S. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.324 · Cited by 517
Homocystinuria: An Enzymatic Defect
Mudd, S. H., Finkelstein, J. D., Irreverre, F., & Laster, L. (1964) · Science · doi:10.1126/science.143.3613.1443 · Cited by 513
Metabolic Abnormalities Detected in a Survey of Mentally Backward Individuals in Northern Ireland
Carson, N. A. J., & Neill, D. W. (1962) · Archives of Disease in Childhood · doi:10.1136/adc.37.195.505 · Cited by 491
Homocysteine and cardiovascular disease: cause or effect?
Brattström, L., & Wilcken, D. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.315 · Cited by 439
Self-citationThe identification of homocystine in the urine
Gerritsen, T., Vaughn, J. G., & Waisman, H. A. (1962) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(62)90114-6 · Cited by 280
Homocystinuria — The Effects of Betaine in the Treatment of Patients Not Responsive to Pyridoxine
Wilcken, D. E. L., Wilcken, B., Dudman, N. P. B., & Tyrrell, P. A. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308253090802 · Cited by 243
Self-citationThe natural history of vascular disease in homocystinuria and the effects of treatment
Wilcken, D. E. L., & Wilcken, B. (1997) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005373209964 · Cited by 224
Self-citationBERG, M. V. D., BOERS, G. H. J., FRANKEN, D. G., BLOM., H. J., VAN KAMP, G. J., JAKOBS, C., RAUWERDA, J. A., KLUFT, C., & STEHOUWERT, C. D. A. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01545.x · Cited by 223
Self-citationThe natural history of homocystinuria due to cystathionine β-synthase deficiency
Mudd, S. H., Skovby, F., Levy, H. L., Pettigrew, K. D., Wilcken, B., Pyeritz, R. E., Andria, G., Boers, G. H. J., Bromberg, I. L., Cerone, R., et al. (1985) · Europe PMC (PubMed Central) · Cited by 159
Self-citationYap, S., & Naughten, E. (1998) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005445132327 · Cited by 149
Self-citationNewborn screening for homocystinuria: Irish and world experience
Naughten, E. R., Yap, S., & Mayne, P. (1998) · European Journal of Pediatrics · doi:10.1007/pl00014310 · Cited by 136
Self-citationYAP, S., NAUGHTEN, E. R., WILCKEN, B., WILCKEN, D. E. L., & BOERS, G. H. J. (2000) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2000-8100 · Cited by 105
Self-citationWalter, J. H., Wraith, J. E., White, F., Bridge, C., & Till, J. (1998) · European Journal of Pediatrics · doi:10.1007/pl00014308 · Cited by 95
Self-citationDietary treatment of homocystinuria.
Komrower, G. M., Lambert, A. M., Cusworth, D. C., & Westall, R. G. (1966) · Archives of Disease in Childhood · doi:10.1136/adc.41.220.666 · Cited by 89
Delay in diagnosis of homocystinuria: retrospective study of consecutive patients
Cruysberg, J. R. M., Boers, G. H. J., Trijbels, J. M. F., & Deutman, A. F. (1996) · BMJ · doi:10.1136/bmj.313.7064.1037 · Cited by 85
Self-citationPrevalence of congenital homocystinuria in Denmark.
Gaustadnes, M., Ingerslev, J., & Rütiger, N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401915 · Cited by 69
Reduction of False Negative Results in Screening of Newborns for Homocystinuria
Peterschmitt, M., Simmons, J. R., & Levy, H. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412103 · Cited by 67
HOMOCYSTINURIA AND MARFAN'S SYNDROME
Brenton, D. P., Dow, C., James, J. I. P., Hay, R., & Wynne-Davies, R. (1972) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.54b2.277 · Cited by 66
Self-citationTREATMENT OF HOMOCYSTINURIA WITH A LOW-METHIONINE DIET, SUPPLEMENTAL CYSTINE, AND A METHYL DONOR
Perry, T., Hansen, S., Love, D., Crawford, L., & Tischler, B. (1968) · The Lancet · doi:10.1016/s0140-6736(68)90646-6 · Cited by 66
Homocysteine and cardiovascular risk
Scott, J. M. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.333 · Cited by 63
Homocystinuria: Reduced folate levels during pyridoxine treatment
Wilcken, B. M., & Turner, B. C. (1973) · Archives of Disease in Childhood · doi:10.1136/adc.48.1.58 · Cited by 40
Self-citationSchulman, J. D., Agarwal, B., Sh, M., & Nr, S. (1978) · New England Journal of Medicine · doi:10.1056/nejm197809212991212 · Cited by 20
Cited by
Facts and recommendations about total homocysteine determinations: an expert opinion
Refsum, H., Smith, A. D., Ueland, P. M., Nexo, E., Clarke, R., McPartlin, J., Johnston, C., Engbaek, F., Schneede, J., McPartlin, C., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.021634 · Cited by 1,056
Refsum, H., Nurk, E., David Smith, A., Ueland, P. M., Gjesdal, C. G., Bjelland, I., Tverdal, A., Tell, G. S., Nygård, O., & Vollset, S. E. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1731s · Cited by 493
Blom, H. J., & Smulders, Y. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9177-4 · Cited by 454
Dichgans, M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70028-5 · Cited by 397
Mechanisms of homocysteine‐induced atherothrombosis
LENTZ, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01364.x · Cited by 363
Metadata
- Authors
- Yap, S., Boers, G. H. J., Wilcken, B., Wilcken, D. E. L., Brenton, D. P., Lee, P. J., Walter, J. H., Howard, P. M., & Naughten, E. R.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2001-12
- Volume
- 21
- Issue
- 12
- Pages
- 2080-2085
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2078369761
- Cited by
- 254
- References
- 29
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.